2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …
IC Van Gelder, M Rienstra, KV Bunting… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Atrial fibrillation and stroke
Introduction Stroke is one of the leading causes of mortality and morbidity globally. Atrial
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
AA Polymeris, TR Meinel, H Oehler… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objective To investigate the aetiology, subsequent preventive strategies and outcomes of
stroke despite anticoagulation in patients with atrial fibrillation (AF). Methods We analysed …
stroke despite anticoagulation in patients with atrial fibrillation (AF). Methods We analysed …
Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral …
Background: In patients with atrial fibrillation who suffered an ischemic stroke while on
treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of …
treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of …
Ischaemic stroke in anticoagulated patients with atrial fibrillation
Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF).
However, recent studies have shown that up to 22%–36% of patients on anticoagulation will …
However, recent studies have shown that up to 22%–36% of patients on anticoagulation will …
Stroke prevention in atrial fibrillation: our current failures and required research
Nonvalvular atrial fibrillation is a common rhythm disorder of middle-aged to older adults that
can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants …
can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants …
Diagnosis and management of cardioembolic stroke
S Yaghi - CONTINUUM: Lifelong Learning in Neurology, 2023 - journals.lww.com
OBJECTIVE Cardioembolic stroke accounts for nearly 30% of ischemic strokes. Prompt
diagnosis of the underlying mechanism may improve secondary prevention strategies. This …
diagnosis of the underlying mechanism may improve secondary prevention strategies. This …
Atrial fibrillation and ischemic stroke despite oral anticoagulation
R Galea, D Seiffge, L Räber - Journal of clinical medicine, 2023 - mdpi.com
Patients with atrial fibrillation (AF) experiencing ischemic stroke despite oral anticoagulation
(OAC), ie, breakthrough strokes, are not uncommon, and represent an important clinical …
(OAC), ie, breakthrough strokes, are not uncommon, and represent an important clinical …
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
M Maarse, DJ Seiffge, DJ Werring… - JAMA …, 2024 - jamanetwork.com
Importance Patients with atrial fibrillation (AF) who have ischemic stroke despite taking oral
anticoagulation therapy (OAT) have a very high risk of recurrence. Left atrial appendage …
anticoagulation therapy (OAT) have a very high risk of recurrence. Left atrial appendage …
Management and prognosis of acute stroke in atrial fibrillation
Atrial fibrillation (AF) is an important risk factor for ischemic stroke (IS). Oral anticoagulation
(OAC) significantly reduces the risk of IS in AF but also increases the risk of systemic …
(OAC) significantly reduces the risk of IS in AF but also increases the risk of systemic …